NO980334D0 - Anvendelse av usubstituerte og substituerte N-(pyrrol-1-yl)pyridinaminer som anti-konvulsive midler - Google Patents

Anvendelse av usubstituerte og substituerte N-(pyrrol-1-yl)pyridinaminer som anti-konvulsive midler

Info

Publication number
NO980334D0
NO980334D0 NO980334A NO980334A NO980334D0 NO 980334 D0 NO980334 D0 NO 980334D0 NO 980334 A NO980334 A NO 980334A NO 980334 A NO980334 A NO 980334A NO 980334 D0 NO980334 D0 NO 980334D0
Authority
NO
Norway
Prior art keywords
pyridinamines
anticonvulsants
pyrrol
unsubstituted
substituted
Prior art date
Application number
NO980334A
Other languages
English (en)
Other versions
NO315148B1 (no
NO980334L (no
Inventor
Francis P Huger
Sathapana Kongsamut
Craig Paul Smith
Lei Tang
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO980334D0 publication Critical patent/NO980334D0/no
Publication of NO980334L publication Critical patent/NO980334L/no
Publication of NO315148B1 publication Critical patent/NO315148B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19980334A 1995-07-27 1998-01-26 Anvendelse av usubstituerte og substituerte N-(pyrrol-1-yl) pyridinaminer som antikonvulsive midler NO315148B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50807195A 1995-07-27 1995-07-27
PCT/US1996/011408 WO1997004777A1 (en) 1995-07-27 1996-07-08 Use off unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents

Publications (3)

Publication Number Publication Date
NO980334D0 true NO980334D0 (no) 1998-01-26
NO980334L NO980334L (no) 1998-03-26
NO315148B1 NO315148B1 (no) 2003-07-21

Family

ID=24021262

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19980334A NO315148B1 (no) 1995-07-27 1998-01-26 Anvendelse av usubstituerte og substituerte N-(pyrrol-1-yl) pyridinaminer som antikonvulsive midler

Country Status (20)

Country Link
EP (1) EP0840609B1 (no)
JP (1) JP4189029B2 (no)
KR (1) KR100445629B1 (no)
CN (1) CN1184969C (no)
AR (1) AR003471A1 (no)
AT (1) ATE218343T1 (no)
AU (1) AU696007B2 (no)
CA (1) CA2225156C (no)
DE (1) DE69621617T2 (no)
DK (1) DK0840609T3 (no)
ES (1) ES2174081T3 (no)
HK (1) HK1015687A1 (no)
IL (1) IL122845A0 (no)
MX (1) MX9800774A (no)
NO (1) NO315148B1 (no)
NZ (1) NZ312577A (no)
PT (1) PT840609E (no)
TW (1) TW464497B (no)
WO (1) WO1997004777A1 (no)
ZA (1) ZA966254B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2897614B1 (fr) * 2006-02-20 2008-05-23 Urogene Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032599A (en) * 1986-11-12 1991-07-16 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-l-yl)pyridinamines
EP0287982B1 (en) * 1987-04-24 1994-12-07 Hoechst-Roussel Pharmaceuticals Incorporated N-(Pyridinyl)-1H-indol-1-amines, a process for their preparation and their use as medicaments
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder

Also Published As

Publication number Publication date
KR19990035973A (ko) 1999-05-25
CN1184969C (zh) 2005-01-19
JP4189029B2 (ja) 2008-12-03
DK0840609T3 (da) 2002-09-30
MX9800774A (es) 1998-04-30
ATE218343T1 (de) 2002-06-15
HK1015687A1 (en) 1999-10-22
AU696007B2 (en) 1998-08-27
NO315148B1 (no) 2003-07-21
IL122845A0 (en) 1998-08-16
AR003471A1 (es) 1998-08-05
NZ312577A (en) 1999-08-30
TW464497B (en) 2001-11-21
DE69621617D1 (de) 2002-07-11
EP0840609A1 (en) 1998-05-13
PT840609E (pt) 2002-10-31
EP0840609B1 (en) 2002-06-05
ZA966254B (en) 1997-02-11
DE69621617T2 (de) 2003-01-02
AU6454796A (en) 1997-02-26
CA2225156A1 (en) 1997-02-13
CN1191486A (zh) 1998-08-26
CA2225156C (en) 2003-06-10
KR100445629B1 (ko) 2004-10-14
NO980334L (no) 1998-03-26
WO1997004777A1 (en) 1997-02-13
ES2174081T3 (es) 2002-11-01
JPH11510159A (ja) 1999-09-07

Similar Documents

Publication Publication Date Title
DK0832061T3 (da) Benzamidderivater og anvendelse deraf som vasopressin-antagonister
NO961664L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som anti-diabetiske midler
NO933240L (no) Anordning ved og fremstilling av tannbörste
NO962322D0 (no) Substituerte N-(indol-2-karbonyl)--alanimamider og derivater som antidiabetiske midler
NO305833B1 (no) Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene
NO984094D0 (no) Utladningsreaktor og anvendelse av samme
DK0731099T3 (da) N-(3-Benzofuranyl)urinstof-derivater
DK0804078T3 (da) Sammensætning og anvendelse deraf
DE69626729D1 (de) Kombination von Datenwerten
NO961346L (no) Benzonitriler og benzofluorider
NO965564D0 (no) Medisinsk anvendelse av bromelain
DE69601430D1 (de) Ver- und entschachtelung von datenelementen
DE59610836D1 (de) Mittel gegen parasitäre protozoen
ID19147A (id) Ksilanase dan pemakaiannya
NO305251B1 (no) Benzamidderivater
FI960425A0 (fi) Fenyylisykloheksyylikarboksyylihappoamidien käyttö
NO20003142D0 (no) Substituerte isokinolin-derivater og anvendelse derav som antikrampemidler
NO980334D0 (no) Anvendelse av usubstituerte og substituerte N-(pyrrol-1-yl)pyridinaminer som anti-konvulsive midler
FI944280A0 (fi) Mingreenin vastaisia indolyylialkyyli-pyridinyyli- ja-pyrimidinyyli-piperatsiinien syklobuteenidionijohdannaisia
NO983556L (no) Formulering og anvendelse
NO963482D0 (no) Medisinsk anvendelse av bromelain
NO20001176D0 (no) Anvendelse av blandinger av polymerer og aminoisothiasoler som biocider
SI0840609T1 (en) Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
NO974941D0 (no) Ny anvendelse av (S)-adenosyl-L-metionin(SAMe)
KR980004510U (ko) 정압의 평균 측정구조

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees